This is the limited version of the Ironwood Pharmaceuticals company profile: Join LinkedIn or Sign In to see more information.
Founded by CEO Peter Hecht, Ironwood is a dynamic young pharmaceutical company with a promising candidate in Phase 3 clinical trials for both Irritable Bowel Syndrome and chronic constipation, and other programs in pain, cardiovascular disease, and inflammation.
Your Connections to Ironwood Pharmaceuticals
Popular Profiles at Ironwood Pharmaceuticals
Last edited by IT Project manager at Ironwood Pharmaceuticals
320 Bent Street
Cambridge, MA
02141
United States
| Top Schools |
| Harvard Univ. | 6% |
| Boston Univ. | 5% |
| Northeastern Univ. | 5% |
|
Estimated based on LinkedIn Data
Career path for Ironwood Pharmaceuticals employees
Ironwood Pharmaceuticals employees are most connected to
This LinkedIn Company Profile was created by LinkedIn and is about Ironwood Pharmaceuticals. This page is not endorsed by or affiliated with Ironwood Pharmaceuticals. For questions regarding LinkedIn Company Profiles, contact us.
